Quibim
Quibim develops AI-powered imaging biomarkers for precision medicine, extracting actionable insights from MRI, CT, and PET scans to improve diagnostics and drug development. Their solutions enable precise characterization of phenotypes and prediction of outcomes in oncology, immunology, neurology, and metabolic disorders, ultimately aiming to create human digital twins.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $50M
Date: 28-Jan-2025
Investors: Asabys, Buenavista, UI Investissements, GoHub Ventures, Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures, Leadwind, individual investors
Markets: Healthtech, AI, Medical Imaging, Oncology, Neurology, Immunology, Biotechnology Research, Diagnostic Equipment, Biotechnology, Therapeutic Devices, Digital Health, Artificial Intelligence & Machine Learning, Life Sciences
HQ: Valencia, Valencia, Spain
Founded: 2012
Website: https://quibim.com/
LinkedIn: https://www.linkedin.com/company/quibim
Twitter: https://twitter.com/quibimbiomarker
Crunchbase: https://www.crunchbase.com/organization/quibim
Leave a Comment
Comments
No comments yet.